AtriCure Historical Financial Ratios

ATRC Stock

USD 33.54 1.28 3.68%

AtriCure is presently reporting on over 110 different financial statement accounts. To analyze all of these accounts together requires a lot of time and effort. However, using these accounts to derive some meaningful and actionable indicators such as Dividend Yield of 0.0, PTB Ratio of 3.71 or Days Sales Outstanding of 56.96 will help investors to properly organize and evaluate AtriCure financial condition quickly.

Quick Ratio Current Ratio

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

About AtriCure Financial Ratios Analysis

AtriCureFinancial ratios are relationships based on a company's financial information. They can serve as useful tools to evaluate AtriCure investment potential. Financial ratio analysis can also be defined as the process of presenting financial ratios, which are mathematical indicators calculated by comparing key financial information appearing on AtriCure financial statements. Financial ratios are useful tools that help investors analyze and compare relationships between different pieces of financial information across AtriCure history.

AtriCure Financial Ratios Chart

At present, AtriCure's Days Sales Outstanding is projected to drop based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 10.28, whereas Price To Sales Ratio is forecasted to decline to 2.94.

Price To Sales Ratio Days Sales Outstanding Free Cash Flow Per Share Days Payables Outstanding

Add Fundamental

Price To Sales Ratio

Price to Sales Ratio is figured by comparing AtriCure stock price to its revenues. An advantage to using Price to Sales ratio is that it is based on AtriCure sales, a figure that is much harder to manipulate than other AtriCure multiples. Because sales tend to be more stable P/S ratio can be a good tool for screening cyclical companies fluctuating earnings patterns. A valuation ratio that compares a company's stock price to its revenues, calculated by dividing the company's market cap by its total sales or revenue over a 12-month period.

Free Cash Flow Per Share

The amount of cash a company generates after accounting for capital expenditures, divided by the number of outstanding shares. It represents the cash available for dividends, share buybacks, or debt repayment per share.

Most ratios from AtriCure's fundamentals are interrelated and interconnected. However, analyzing fundamentals ratios one by one will only give a small insight into AtriCure current financial condition. On the other hand, looking into the entire matrix of fundamentals ratios, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in AtriCure. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.At present, AtriCure's Days Sales Outstanding is projected to drop based on the last few years of reporting. The current year's Book Value Per Share is expected to grow to 10.28, whereas Price To Sales Ratio is forecasted to decline to 2.94.

	2022	2023	2024	2025 (projected)
Days Sales Outstanding	47.17	48.0	47.33	56.96
PTB Ratio	4.44	3.55	3.12	3.71

Days Sales Outstanding Ptb Ratio

AtriCure fundamentals Correlations

	Price To Sales Ratio	Ptb Ratio	Days Sales Outstanding	Book Value Per Share	Free Cash Flow Yield	Operating Cash Flow Per Share	Average Payables	Capex To Depreciation	Pb Ratio	Ev To Sales	Free Cash Flow Per Share	Roic	Inventory Turnover	Net Income Per Share	Days Of Inventory On Hand	Payables Turnover	Average Inventory	Capex To Revenue	Cash Per Share	Pocfratio	Interest Coverage	Capex To Operating Cash Flow	Pfcf Ratio	Days Payables Outstanding	Income Quality	Roe
Price To Sales Ratio		0.73	0.59	-0.41	-0.93	-0.85	-0.82	-0.01	0.73	1.0	-0.83	-0.44	0.78	-0.54	-0.53	0.74	-0.87	0.09	0.13	0.05	-0.14	-0.09	0.09	-0.52	0.08	-0.95
Ptb Ratio	0.73		0.46	-0.67	-0.69	-0.62	-0.51	-0.29	1.0	0.73	-0.53	-0.75	0.79	-0.15	-0.63	0.42	-0.56	-0.28	-0.07	-0.18	0.08	-0.3	-0.15	-0.29	0.07	-0.82
Days Sales Outstanding	0.59	0.46		-0.6	-0.66	-0.5	-0.62	0.32	0.46	0.59	-0.49	-0.52	0.67	-0.37	-0.65	0.17	-0.63	0.31	-0.43	0.19	-0.45	-0.03	0.37	0.14	0.35	-0.63
Book Value Per Share	-0.41	-0.67	-0.6		0.58	0.45	0.16	0.23	-0.67	-0.41	0.37	0.84	-0.74	0.22	0.77	-0.07	0.21	0.2	0.53	0.19	0.18	0.5	0.06	-0.01	-0.46	0.61
Free Cash Flow Yield	-0.93	-0.69	-0.66	0.58		0.92	0.64	-0.04	-0.69	-0.93	0.93	0.56	-0.8	0.52	0.6	-0.58	0.71	-0.17	0.03	-0.01	0.37	0.3	0.02	0.42	-0.34	0.93
Operating Cash Flow Per Share	-0.85	-0.62	-0.5	0.45	0.92		0.53	0.21	-0.62	-0.85	0.93	0.38	-0.66	0.45	0.49	-0.59	0.6	0.04	-0.17	0.22	0.31	0.45	0.21	0.49	-0.49	0.81
Average Payables	-0.82	-0.51	-0.62	0.16	0.64	0.53		-0.2	-0.51	-0.82	0.48	0.28	-0.7	0.54	0.54	-0.68	0.99	-0.23	-0.05	-0.25	0.02	-0.28	-0.49	0.37	0.15	0.76
Capex To Depreciation	-0.01	-0.29	0.32	0.23	-0.04	0.21	-0.2		-0.29	-0.01	-0.04	0.09	-0.1	-0.19	0.17	-0.19	-0.17	0.95	-0.21	0.6	-0.56	0.47	0.58	0.33	-0.21	0.03
Pb Ratio	0.73	1.0	0.46	-0.67	-0.69	-0.62	-0.51	-0.29		0.73	-0.53	-0.75	0.79	-0.15	-0.63	0.42	-0.56	-0.28	-0.07	-0.18	0.08	-0.3	-0.15	-0.29	0.07	-0.82
Ev To Sales	1.0	0.73	0.59	-0.41	-0.93	-0.85	-0.82	-0.01	0.73		-0.83	-0.44	0.78	-0.54	-0.53	0.74	-0.87	0.09	0.13	0.05	-0.14	-0.09	0.09	-0.52	0.08	-0.95
Free Cash Flow Per Share	-0.83	-0.53	-0.49	0.37	0.93	0.93	0.48	-0.04	-0.53	-0.83		0.31	-0.57	0.46	0.36	-0.49	0.55	-0.22	-0.14	0.03	0.45	0.36	0.22	0.39	-0.4	0.77
Roic	-0.44	-0.75	-0.52	0.84	0.56	0.38	0.28	0.09	-0.75	-0.44	0.31		-0.8	0.13	0.75	-0.15	0.32	0.12	0.47	0.1	0.1	0.34	-0.06	0.08	-0.2	0.66
Inventory Turnover	0.78	0.79	0.67	-0.74	-0.8	-0.66	-0.7	-0.1	0.79	0.78	-0.57	-0.8		-0.42	-0.92	0.58	-0.73	-0.05	-0.26	-0.11	-0.1	-0.27	0.14	-0.36	0.18	-0.9
Net Income Per Share	-0.54	-0.15	-0.37	0.22	0.52	0.45	0.54	-0.19	-0.15	-0.54	0.46	0.13	-0.42		0.31	-0.52	0.56	-0.28	-0.15	-0.31	0.18	-0.09	-0.44	0.38	-0.29	0.57
Days Of Inventory On Hand	-0.53	-0.63	-0.65	0.77	0.6	0.49	0.54	0.17	-0.63	-0.53	0.36	0.75	-0.92	0.31		-0.38	0.54	0.11	0.45	0.27	0.14	0.39	-0.13	0.17	-0.29	0.68
Payables Turnover	0.74	0.42	0.17	-0.07	-0.58	-0.59	-0.68	-0.19	0.42	0.74	-0.49	-0.15	0.58	-0.52	-0.38		-0.72	-0.09	0.45	-0.04	0.18	0.07	0.15	-0.91	0.01	-0.67
Average Inventory	-0.87	-0.56	-0.63	0.21	0.71	0.6	0.99	-0.17	-0.56	-0.87	0.55	0.32	-0.73	0.56	0.54	-0.72		-0.21	-0.07	-0.23	0.04	-0.23	-0.45	0.41	0.12	0.82
Capex To Revenue	0.09	-0.28	0.31	0.2	-0.17	0.04	-0.23	0.95	-0.28	0.09	-0.22	0.12	-0.05	-0.28	0.11	-0.09	-0.21		-0.16	0.48	-0.72	0.3	0.49	0.22	-0.1	-0.04
Cash Per Share	0.13	-0.07	-0.43	0.53	0.03	-0.17	-0.05	-0.21	-0.07	0.13	-0.14	0.47	-0.26	-0.15	0.45	0.45	-0.07	-0.16		-0.07	0.22	0.13	-0.28	-0.51	-0.06	0.03
Pocfratio	0.05	-0.18	0.19	0.19	-0.01	0.22	-0.25	0.6	-0.18	0.05	0.03	0.1	-0.11	-0.31	0.27	-0.04	-0.23	0.48	-0.07		0.09	0.84	0.59	0.09	-0.26	-0.05
Interest Coverage	-0.14	0.08	-0.45	0.18	0.37	0.31	0.02	-0.56	0.08	-0.14	0.45	0.1	-0.1	0.18	0.14	0.18	0.04	-0.72	0.22	0.09		0.36	-0.05	-0.27	-0.42	0.12
Capex To Operating Cash Flow	-0.09	-0.3	-0.03	0.5	0.3	0.45	-0.28	0.47	-0.3	-0.09	0.36	0.34	-0.27	-0.09	0.39	0.07	-0.23	0.3	0.13	0.84	0.36		0.65	0.0	-0.54	0.16
Pfcf Ratio	0.09	-0.15	0.37	0.06	0.02	0.21	-0.49	0.58	-0.15	0.09	0.22	-0.06	0.14	-0.44	-0.13	0.15	-0.45	0.49	-0.28	0.59	-0.05	0.65		0.01	-0.18	-0.13
Days Payables Outstanding	-0.52	-0.29	0.14	-0.01	0.42	0.49	0.37	0.33	-0.29	-0.52	0.39	0.08	-0.36	0.38	0.17	-0.91	0.41	0.22	-0.51	0.09	-0.27	0.0	0.01		-0.07	0.48
Income Quality	0.08	0.07	0.35	-0.46	-0.34	-0.49	0.15	-0.21	0.07	0.08	-0.4	-0.2	0.18	-0.29	-0.29	0.01	0.12	-0.1	-0.06	-0.26	-0.42	-0.54	-0.18	-0.07		-0.14
Roe	-0.95	-0.82	-0.63	0.61	0.93	0.81	0.76	0.03	-0.82	-0.95	0.77	0.66	-0.9	0.57	0.68	-0.67	0.82	-0.04	0.03	-0.05	0.12	0.16	-0.13	0.48	-0.14

Click cells to compare fundamentals

AtriCure Account Relationship Matchups

AtriCure fundamentals Accounts

	2020	2021	2022	2023	2024	2025 (projected)
Price To Sales Ratio	11.35	11.42	6.14	4.14	3.09	2.94
Ptb Ratio	5.69	6.48	4.44	3.55	3.12	3.71
Days Sales Outstanding	40.91	43.94	47.17	48.0	47.33	56.96
Book Value Per Share	6.58	9.79	10.73	9.99	10.07	10.28
Free Cash Flow Yield	(0.0107)	(0.00751)	(0.0192)	(0.0227)	0.008478	0.008902
Operating Cash Flow Per Share	(0.42)	(0.47)	(0.31)	0.0968	0.26	0.27
Stock Based Compensation To Revenue	0.11	0.1	0.0871	0.0895	0.0805	0.0573
Capex To Depreciation	0.55	0.93	1.44	2.84	2.55	2.68
Pb Ratio	5.69	6.48	4.44	3.55	3.12	3.71
Ev To Sales	11.51	11.54	6.18	4.12	2.99	2.84
Free Cash Flow Per Share	(0.6)	(0.52)	(0.85)	(0.81)	0.26	0.27
Roic	(0.066)	(0.084)	(0.0811)	(0.0502)	(0.076)	(0.0798)
Inventory Turnover	1.63	1.76	1.84	1.46	1.56	2.62
Net Income Per Share	(1.14)	1.11	(1.02)	(0.66)	(0.95)	(1.0)
Days Of Inventory On Hand	223.42	207.71	198.54	250.64	233.46	133.18
Payables Turnover	4.49	3.68	4.24	3.61	4.71	4.41
Capex To Revenue	0.0255	0.0356	0.0511	0.11	0.0947	0.0994
Cash Per Share	5.8	2.64	2.65	2.96	2.61	1.74
Pocfratio	(118.03)	(227.39)	(91.68)	368.59	117.96	123.85
Interest Coverage	(9.05)	(9.62)	(8.56)	(3.85)	(6.25)	(6.56)
Pfcf Ratio	(93.33)	(133.15)	(52.02)	(44.06)	117.96	123.85
Days Payables Outstanding	81.24	99.14	86.01	100.98	77.57	108.57
Income Quality	0.41	(0.27)	0.48	(0.15)	(0.17)	(0.16)
Ev To Operating Cash Flow	(119.64)	(229.71)	(92.18)	366.4	114.17	119.88
Pe Ratio	(48.7)	62.42	(43.69)	(54.3)	(32.21)	(33.82)
Ev To Free Cash Flow	(94.6)	(134.51)	(52.3)	(43.8)	114.17	119.88
Earnings Yield	(0.0205)	0.016	(0.0229)	(0.0184)	(0.0311)	(0.0326)
Intangibles To Total Assets	0.51	0.45	0.47	0.49	0.48	0.26
Net Debt To E B I T D A	(0.95)	(0.87)	(0.37)	1.21	2.49	2.62
Current Ratio	2.87	6.24	3.47	3.69	3.57	3.81
Tangible Book Value Per Share	1.17	4.57	3.99	3.61	3.6	3.78
Receivables Turnover	8.92	8.31	7.74	7.6	7.71	5.74
Shareholders Equity Per Share	6.58	9.79	10.73	9.99	10.07	10.28

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

ZLAB	Zai Lab
ASLE	AerSale Corp
ATS	AT S Austria

When determining whether AtriCure offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of AtriCure's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Atricure Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Atricure Stock:

How To Invest In AtriCure

Details

Is AtriCure Stock a good investment?

Details

What is AtriCure's Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

For information on how to trade AtriCure Stock refer to our How to Trade AtriCure Stock guide.

You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.

Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of AtriCure. If investors know AtriCure will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about AtriCure listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.95)

Revenue Per Share

9.908

Quarterly Revenue Growth

0.166

Return On Assets

(0.04)

Return On Equity

(0.1)

The market value of AtriCure is measured differently than its book value, which is the value of AtriCure that is recorded on the company's balance sheet. Investors also form their own opinion of AtriCure's value that differs from its market value or its book value, called intrinsic value, which is AtriCure's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because AtriCure's market value can be influenced by many factors that don't directly affect AtriCure's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between AtriCure's value and its price as these two are different measures arrived at by different means. Investors typically determine if AtriCure is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, AtriCure's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Price To Sales Ratio	Dividend Yield
Ptb Ratio	Days Sales Outstanding
Book Value Per Share	Free Cash Flow Yield
Invested Capital	Operating Cash Flow Per Share
Average Payables	Stock Based Compensation To Revenue
Capex To Depreciation	Pb Ratio
Ev To Sales	Free Cash Flow Per Share
Roic	Inventory Turnover
Net Income Per Share	Days Of Inventory On Hand
Payables Turnover	Sales General And Administrative To Revenue
Average Inventory	Research And Ddevelopement To Revenue
Capex To Revenue	Cash Per Share
Pocfratio	Interest Coverage
Payout Ratio	Capex To Operating Cash Flow
Pfcf Ratio	Days Payables Outstanding
Net Current Asset Value	Income Quality
Roe	Tangible Asset Value
Ev To Operating Cash Flow	Pe Ratio
Return On Tangible Assets	Ev To Free Cash Flow
Earnings Yield	Intangibles To Total Assets
Net Debt To E B I T D A	Current Ratio
Tangible Book Value Per Share	Receivables Turnover
Shareholders Equity Per Share	Debt To Equity
Capex Per Share	Graham Net Net
Average Receivables	Revenue Per Share
Interest Debt Per Share	Debt To Assets
Enterprise Value Over E B I T D A	Graham Number
Short Term Coverage Ratios	Price Earnings Ratio
Operating Cycle	Price Book Value Ratio
Price Earnings To Growth Ratio	Days Of Payables Outstanding
Dividend Payout Ratio	Price To Operating Cash Flows Ratio
Price To Free Cash Flows Ratio	Pretax Profit Margin
Ebt Per Ebit	Operating Profit Margin
Effective Tax Rate	Company Equity Multiplier
Long Term Debt To Capitalization	Total Debt To Capitalization
Return On Capital Employed	Debt Equity Ratio
Ebit Per Revenue	Quick Ratio
Dividend Paid And Capex Coverage Ratio	Net Income Per E B T
Cash Ratio	Cash Conversion Cycle
Operating Cash Flow Sales Ratio	Days Of Inventory Outstanding
Days Of Sales Outstanding	Free Cash Flow Operating Cash Flow Ratio
Cash Flow Coverage Ratios	Price To Book Ratio
Fixed Asset Turnover	Capital Expenditure Coverage Ratio
Price Cash Flow Ratio	Enterprise Value Multiple
Debt Ratio	Cash Flow To Debt Ratio
Price Sales Ratio	Return On Assets
Asset Turnover	Net Profit Margin
Gross Profit Margin	Price Fair Value
Return On Equity

AtriCure Historical Financial Ratios

About AtriCure Financial Ratios Analysis

AtriCure Financial Ratios Chart

Price To Sales Ratio

Free Cash Flow Per Share

AtriCure fundamentals Correlations

AtriCure Account Relationship Matchups

High Positive Relationship

High Negative Relationship

AtriCure fundamentals Accounts

Also Currently Popular

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Ev To Sales	+ 1.0	Price To Sales Ratio
Pb Ratio	+ 1.0	Ptb Ratio
Average Inventory	+ 0.99	Average Payables
Capex To Revenue	+ 0.95	Capex To Depreciation
Free Cash Flow Per Share	+ 0.93	Free Cash Flow Yield
Roe	+ 0.93	Free Cash Flow Yield

Roe	- 0.95	Ev To Sales
Roe	- 0.95	Price To Sales Ratio
Ev To Sales	- 0.93	Free Cash Flow Yield
Free Cash Flow Yield	- 0.93	Price To Sales Ratio
Days Of Inventory On Hand	- 0.92	Inventory Turnover
Days Payables Outstanding	- 0.91	Payables Turnover